207.83 USD
↗ 0.28 (0.14%)AT CLOSE (11:59 AM EDT)
IQVIA Holdings Inc.
IQVNYSE • USD
206.76
↘ 1.07 (0.51%)
POST MARKET (AS OF 05:46 PM EDT)
Post Market
AS OF 05:46 PM EDT
206.76
↘ 1.07 (0.51%)
Market: OPEN
IQVIA Holdings Inc. (IQV) trades at $206.76 per share. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. Notable factors include exceptional Return on Equity (22.3%) and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jul 14, 2026.
Open?$205.01
High?$208.61
Low?$202.76
Prev. Close?$207.55
Volume?1.1M
Avg. Volume?1.6M
VWAP?$207.27
Rel. Volume?0.71x
Bid / Ask
Bid?$196.85 × 300
Ask?$214.45 × 100
Spread?$17.60
Midpoint?$205.65
Valuation & Ratios
Market Cap?34.6B
Shares Out?166.9M
Float?160.5M
Float %?94.6%
P/E Ratio?25.01
P/B Ratio?5.57
EPS?$8.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Themes
Employees
93.0K
Market Cap
34.6B
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Website
Listed
2013-05-09
Address
2400 ELLIS ROAD
DURHAM, NC 27703
Phone: 919-998-2000
DURHAM, NC 27703
Phone: 919-998-2000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?51
Momentum?90
Short Sent.?55
Piotroski F-Score?5/9Mixed
Altman Z-Score?2.44Grey
Confidence?74%Moderate
Short InterestLow
Short % of Float?3.10%Low
Short Interest?5.0M
Days to Cover?2.7
Free Float160.5M
Avg Daily Volume1.8M
Settlement Date2026-06-30
Financial Health
Current Ratio?0.75Weak
Quick Ratio?0.75Weak
Cash Ratio?0.23Low
Debt/Equity?2.55High
ValuationATTRACTIVELY VALUEDvs 10 peers + S&P 500
Score83/100
P/E?25.0FAIR▾
Peers100
S&P48
P/B?5.57FAIR▾
Peers30
S&P33
P/S?2.08CHEAP▾
Peers100
S&P65
P/FCF?16.4CHEAP▾
Peers100
S&P69
EV/EBITDA?13.9FAIR▾
Peers100
S&P57
EV/Sales?2.92CHEAP▾
Peers100
S&P62
Returns & Efficiency
ROE?22.3%STRONG▾
Peers89
S&P70
ROA?4.7%FAIR▾
Peers50
S&P42
Cash Flow & Enterprise
FCF?$2.1B
Enterprise Value?$48.5B
Fundamentals ratios updated end of day